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Background—Survivors of the Norwood procedure may suffer neurodevelopmental
impairment. Clinical trials to improve outcomes have focused primarily on methods of vital organ
support during cardiopulmonary bypass.
Methods—In the Single Ventricle Reconstruction trial of the Norwood procedure with modified
Blalock-Taussig shunt vs. right-ventricle-to-pulmonary-artery shunt, 14-month
neurodevelopmental outcome was assessed using the Psychomotor Development Index (PDI) and
Mental Development Index (MDI) of the Bayley Scales of Infant Development®-II. We used
multivariable regression to identify risk factors for adverse outcome.
Results—Among 373 transplant-free survivors, 321 (86%) returned at age 14.3±1.1 (mean±SD)
months. Mean PDI (74±19) and MDI (89±18) scores were lower than normative means (each P<.
001). Neither PDI or MDI score was associated with type of Norwood shunt. Independent
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predictors of lower PDI score (R2= 26%) were clinical center (P=.003), birth weight<2.5 kg (P=.
023), longer Norwood hospitalization (P<.001), and more complications between Norwood
procedure discharge and age 12 months (P<.001). Independent risk factors for lower MDI score
(R2= 34%) included center (P<.001), birth weight<2.5 kg (P=.04), genetic syndrome/anomalies
(P=.04), lower maternal education (P=.04), longer mechanical ventilation after the Norwood
procedure (P<.001), and more complications after Norwood discharge to age 12 months (P<.001).
We found no significant relationship of PDI or MDI score to, perfusion type, other aspects of vital
organ support (e.g. hematocrit, pH strategy), or cardiac anatomy.
Conclusion—Neurodevelopmental impairment in Norwood survivors is more highly associated
with innate patient factors and overall morbidity in the first year than with intraoperative
management strategies. Improved outcomes are likely to require interventions that occur outside
the operating room.

INTRODUCTION
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Survival to adulthood is becoming a reality for patients with hypoplastic left heart syndrome
(HLHS) and other single right ventricle (RV) anomalies treated with staged repair from the
Norwood operation to the Fontan procedure. This remarkable progress has exposed a high
prevalence of neurodevelopmental impairment in survivors,1–5 affecting their educational
achievement, employability, and quality of life.6, 7 Potential risk factors for adverse
neurodevelopmental outcome in this population include patient and environmental
factors,8–12 management practices,13–22 and medical course.23, 24
The Single Ventricle Reconstruction (SVR) trial compared outcomes in subjects with HLHS
or related anomalies palliated using the Norwood procedure with either a modified BlalockTaussig (MBT) shunt or the right-ventricular-to-pulmonary-artery (RV-to-PA) shunt. The
primary outcome was freedom from death or cardiac transplantation by 12 months postrandomization.25 In this manuscript, we report an important pre-specified secondary trial
outcome, neurodevelopment assessed by in-person evaluation at 14 months after
randomization. We evaluated the influence of shunt type on neurodevelopmental outcome
based on the hypothesis that the RV-to-PA shunt group would have better
neurodevelopment because of its potential advantage of reducing the aortic diastolic run-off
and hence improving cerebral blood supply in the early postoperative period. As a secondary
analysis, multivariable regression was used to identify other risk factors for adverse
neurodevelopmental outcome. The SVR trial is the largest prospective study of children
undergoing the Norwood procedure. Developmental testing at age 14 months in this cohort
provides an unparalleled opportunity to explore the correlates of neurodevelopment, and to
identify potential modifiable factors.
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METHODS
Subjects
Details of the SVR trial design have been published.26 Patients were recruited from 15
centers in North America participating in the NHLBI-funded Pediatric Heart Network
between May 2005 and July 2008. Inclusion criteria consisted of a diagnosis of HLHS or
other single, morphologic RV anomaly and planned Norwood procedure. Exclusion criteria
included preoperative identification of anatomy rendering either a MBT shunt or a RV-toPA shunt technically impossible and any major congenital or acquired extra-cardiac
abnormality that could independently affect the likelihood of the subject meeting the
primary outcome of transplant-free survival at 12 months post-randomization. The protocol
was approved by the Institutional Review Board at each center, and written informed
consent was obtained from a parent/guardian prior to randomization.
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The primary measure of neurodevelopment was the Bayley Scales of Infant Development®Second Edition (BSID–II).27 Every examiner participated in conference calls in which the
study protocol, the certification process, and data reporting procedures were discussed. Each
submitted two videotaped assessments of children similar in age to trial subjects in order to
be certified by a single expert (D.C.B.) prior to administering the BSID-II to a trial subject.
These tapes, and the associated examiner record forms, were reviewed to ensure that
appropriate administration and scoring procedures were followed. Throughout the study, the
examiner record form for each trial subject was reviewed by D.C.B. for completeness and
accuracy. The BSID-II was only administered in English or Spanish and it was administered
in the dominant language spoken in the home. Testing personnel were blinded to the
treatment assignment of the subjects.
The BSID-II offers a standardized assessment of cognitive and motor development for
children ages 1 month through 42 months.27 It yields two scores: the Psychomotor
Development Index (PDI) and the Mental Development Index (MDI). The mean±standard
deviation (SD) for PDI and MDI scores in the normative population is 100±15.
Study Design and Measurements
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Subjects were randomly assigned to either a MBT shunt or a RV-to-PA shunt within strata
defined by the presence or absence of aortic atresia and of obstructed pulmonary venous
return, with dynamic balancing within surgeon. In all other respects, they were managed
according to the usual practices at their clinical centers. A complete list of variables that
were recorded and analyzed is provided in the Supplemental Table. In brief, prior to the
Norwood procedure, we recorded demographic and preoperative medical history, including
pregnancy history, fetal diagnosis, birth weight, race, gender, gestational age, Apgar scores,
clinical status and anatomic diagnosis at presentation, occurrence of important preoperative
complications, and age at operation.26 We recorded intra-operative variables at the time of
the Norwood procedure, the stage II procedure, and any additional cardiac operations,
including total support time, total bypass time, and durations of deep hypothermic
circulatory arrest (DHCA) and regional cerebral perfusion RCP) times; details of bypass
(e.g., lowest temperature, use of modified ultrafiltration, use of alpha blockade); and shunt
type. The perfusion method during vital organ support was classified as deep hypothermic
circulatory arrest (DHCA), regional cerebral perfusion (RCP), or DHCA+RCP. Patients who
received RCP with ≤10 minutes of DHCA, usually to allow for repositioning of cannulae,
were classified in the RCP group. Shunt type was defined as the shunt in place at the end of
the Norwood procedure, which differed from the randomly assigned shunt for 22 (7%) of
subjects with a Bayley score. Postoperative data during the admissions for the Norwood and
stage II operations were prospectively collected by daily review, and included procedures
and events. Twelve months after randomization, we recorded vital status and interim
medical history. At the in-person evaluation 14 months after randomization, we performed
neurodevelopmental testing and collected data on height, weight, head circumference,
interim medical history, and socioeconomic status. In addition to genetic evaluations
performed during routine clinical care, an optional research genetic evaluation was offered
to families. Patients were classified with regard to whether they had 1) a specific genetic
syndrome, or 2) other anomalies (i.e., not identified with a syndrome). Growth data were
converted into age-adjusted z-scores based on World Health Organization standards.28
Statistical Methods
Descriptive statistics include median with interquartile range for skewed variables, mean
±SD for other continuous variables, and frequency with percentage for categorical variables.
The frequency distributions of duration of mechanical ventilation and hospital stay were
Circulation. Author manuscript; available in PMC 2013 May 01.
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nonlinearly related to outcome; thus we used a natural logarithmic transformation. We used
median imputation for highest lactate level with values specific to pre-intubation status (101
subjects) and mean imputation for Apgar scores (20 subjects). For the Bayley scores,
interactions between each candidate predictor and four pre-specified variables were
examined: 1) birth weight <2.5 kg vs. ≥2.5 kg; 2) gestational age <37 weeks vs. ≥37 weeks;
3) Pre-Norwood head circumference z-score < −1 vs. ≥ −1; and 4) presence vs. absence vs.
unknown status of a genetic syndrome or other abnormality. We used simple linear
regression and regressions adjusted for site to obtain initial estimates of association of each
candidate predictor with PDI and MDI scores. All variables with unadjusted P<0.20 were
used as candidate predictors for multivariable modeling. Interaction terms were allowed to
enter the multivariable model only in hierarchical fashion. Stepwise linear regression was
employed to develop multivariable models, in conjunction with bootstrapping (1000
samples) to obtain reliability estimates for each of the predictors. We required that all terms
in the final multivariable model have a reliability >50% and P<.05. All analyses were
conducted using SAS version 9.2 (Statistical Analysis System, SAS Institute, Inc., Cary,
NC) and SAS macros for bootstrapping estimates of reliability.

RESULTS
NIH-PA Author Manuscript

A flow chart of SVR trial subjects from randomization to neurodevelopmental follow-up is
shown in Figure 1. The follow-up rate for the BSID-II examination among transplant-free
survivors was 86%. The mean (±SD) age at follow-up was 14.3±1.1 months (range 12.2–
19.5 months). The 314 patients who completed the examination were less likely to be of
black or other race (P<.001). However, the groups did not differ in their socioeconomic class
or level of highest maternal education. The mean time interval between the Norwood and
stage II procedures was 5.2±1.9 months (median 5.0 months). Ten (3%) subjects in the
cohort were not discharged between stage I and II surgery.
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At 14 months, children had impaired growth: mean weight, height, and head circumference
z-scores-for-age were −0.7±1.1, −1.3±1.7, and −0.4±1.4, respectively. Among the 296
subjects for whom a parent history was available, 47% had received developmental support
in the first year of life: 39% with physical therapy, 26% with speech/language therapy, 10%
with early intervention, and 4% with other forms of support. Genetic syndromes or other
anomalies were detected in 25% of the cohort and were absent in 57%; the remaining 18%
were not evaluated by a geneticist. Subjects with confirmed genetic syndrome and other
anomalies had longer hospitalization (median 28 days [IQR 20–43 days] vs. 22 days [IQR
16 – 35 days] and 24 days [IQR 17–38 days] for no and unknown syndrome status, P=.01).
Birth weight tended to be lower in the patients with confirmed genetic syndromes (3.0±0.6
vs. 3.2±0.5 or 3.2±0.5 kg in the no and unknown groups, P=.06).
Distributions of PDI and MDI scores are depicted in Figure 2. Tables 1 and 2 summarize the
significant univariate associations (P≤.05) of PDI or MDI score with patient factors,
management practices, and medical course.
For the overall cohort, PDI scores were profoundly lower than in the normative population
(Figure 2): scores were < 85 (>1 SD below expected mean) in 65% of subjects, and <70 (>2
SD below expected mean) in 44% of subjects. The subgroup of subjects with no genetic
syndrome and birth weight of ≥2.5 kg had the highest PDI and MDI scores (each P<.001)
and also had shorter Norwood hospital length of stay (P=.033). Subjects who received the
MBT shunt and RV-to-PA shunt had similar PDI scores (75±19 vs. 74±20, respectively,
P=0.48; Supplemental Figure). In multivariable linear regression modeling (Table 3),
independent predictors of lower PDI scores were clinical center where the Norwood
procedure was performed (P=.003), birth weight <2.5 kg (P=.02), longer log-transformed
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days of Norwood hospitalization (P<.001), and greater number of complications between the
time of discharge after the Norwood procedure and age 12 months (P<.001). The percentage
of variance explained by the model (adjusted R2) was 26%. Mean PDI score dropped
approximately 13 points for every three extra days of hospital stay during the Norwood
hospitalization. Presence of a genetic syndrome or other anomaly did not achieve statistical
significance (P=.07).
MDI scores were also much lower than in the normative population (Figure 2): scores were
< 85 (>1 SD below normal mean) in 36% of subjects, and <70 (>2 SD below normal mean)
in 16% of subjects. Within subject, MDI scores were higher than PDI scores (P<.001). Mean
MDI scores did not differ significantly between patients who received the MBT shunt vs. the
RV-to-PA shunt (89±17 vs. 88±18, respectively, P=.55; eFigure 1). In multivariable
regression analysis (Table 3), independent predictors of lower MDI score included the
clinical center where the Norwood procedure was performed (P<.001), birth weight <2.5 kg
(P=.04), the presence of a genetic syndrome or other anomalies (P=.04), lower maternal
education level (P=.04), longer log days on the ventilator after the Norwood procedure (P<.
001), and a greater number of complications between the time of hospital discharge after the
Norwood procedure and age 12 months (P<.001). The percentage of variance explained by
the model (adjusted R2) was 34%. Birth weight percentile for gestational age was a less
significant predictor for PDI and MDI scores than raw birth weight.

NIH-PA Author Manuscript
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Early intervention in the first year of life was not included in our original multivariable
models, because it was considered to be a correlate of adverse outcome. However, the
percentage of subjects who received early intervention varied significantly by center,
ranging from 0% to 23% (p=0.02) for early intervention administered for the indication of a
cognitive disorder and from 0% to 78% for receipt of any form of early intervention (e.g.,
physical therapy, occupational therapy). We therefore explored whether center differences in
the percentages of children receiving either early intervention for a cognitive disorder or any
form of early intervention in the first year of life could explain the center effect on
outcomes. Mean PDI and MDI scores were significantly lower on average by 11 points in
those who received early intervention for a cognitive disorder compared to those who did
not (PDI, 66.4±18.0 vs. 75.5±19.3, P=.014 ; MDI, 78.7±20.7 vs. 90.1±17.0, P<.001).
Similarly, children who received any form of early intervention in the first year of life (e.g.,
physical therapy, occupational therapy) fared worse than those who received no form of
early intervention (PDI, 67.8±18.3 vs. 81.5±17.9, P<.001 ; MDI, 84.1±19.0 vs. 93.9±14.7,
P<.001). However, adjustment for either of these intervention terms in the final
multivariable models for MDI and PDI did not appreciably alter the effects of center on
developmental scores. Similarly, we could find no other center characteristics, such as center
volume or surgeon volume, which had a significant effect on PDI or MDI score in
multivariable analysis. Finally, we explored whether the center effect could be related to an
outlier; when eliminating centers one at a time from the multivariable models; study
inferences were similar.
Some variables that had been hypothesized to predict developmental outcome were notable
for their lack of association with either PDI or MDI scores. Perfusion type examined both as
a categorical variable (DHCA, RCP, or DHCA together with RCP), and as total minutes of
DHCA during Norwood surgery was not associated with PDI score in univariate analyses.
MDI scores differed (P<.001) in univariate analysis among patients who underwent vital
organ support during the Norwood procedure using DHCA, RCP, or a combination of
DHCA and RCP (mean scores 85.1, 93.4, and 92.0, respectively, P<.001). As noted above,
perfusion type was not an independent predictor of MDI in multivariable analysis. Because
the final multivariable model included clinical center, we further explored whether perfusion
type would become an independent predictor of MDI if site were not considered. Even then,
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perfusion strategy did not meet the criteria for inclusion because of low reliability by
bootstrapping (40%). In addition, we found no significant relationship of PDI or MDI score
to other aspects of vital organ support, such as hematocrit or pH strategy during core cooling
or to patient factors such as diameter of the ascending aorta or cardiac anatomy.
Finally, we assessed whether the strength of the candidate predictors varied according to
four pre-specified patient factors (see Methods) related to birth weight, preterm status, preNorwood head circumference z-score, and presence of a genetic syndrome or other
anomalies. The lack of effect of shunt type on PDI and MDI scores was consistent across the
predetermined subgroups. The association of other candidate predictors with outcome also
did not vary according to these pre-specified patient factors. None of the interaction terms
entered the final multivariable models for either MDI or PDI.

DISCUSSION

NIH-PA Author Manuscript

We found a high prevalence of neurodevelopmental impairment in patients with HLHS
syndrome and other single right ventricle anomalies, discouragingly similar to that described
in patients who underwent Norwood surgery from 1998 to 2003.5 Lower BSID-II scores at
age 14 months were predicted by both innate patient factors and measures of greater severity
of illness. Patient factors that portended greater risk included the presence of genetic
syndromes or other anomalies, lower maternal education, and lower birth weight. Consistent
with previous reports,23, 24 patients in our study with a more complicated postoperative
course following the Norwood procedure also had worse outcomes, as indicated by
independent risk factors of longer postoperative mechanical ventilation or hospital stay.
These measures of longer recovery likely integrate the effects of many other factors during
the Norwood hospitalization, including adverse events, low cardiac output, poor feeding, or
comorbidities. Between Norwood discharge and age 12 months, a greater number of
complications were also associated with worse development, a novel finding that highlights
ongoing brain vulnerability and opportunities for intervention. Subjects whose Norwood
procedure was performed using the recently popularized RV-to-PA shunt scored no better
on the BSID-II than those receiving a MBT shunt, even though they had better early
survival.25 Thus, patient characteristics and indices of greater severity of illness were more
highly associated with later neurodevelopmental outcome than specific operative
management strategies.
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Methods of vital organ support during infant heart surgery are among the best studied and
most easily modified potential risk factors for brain injury. Previous studies have suggested
that longer duration of DHCA may have adverse effects on neurodevelopmental
outcomes.2, 29 An alternative to DHCA, RCP involves low-flow perfusion to the brain
during aortic arch reconstruction and has been hypothesized to be potentially
neuroprotective relative to DHCA. A single-center randomized trial comparing DHCA to
RCP during Norwood surgery found no evidence that RCP improves infant development at
age one year.30 Nonetheless, half of surgeons who responded to a survey on support
techniques recently reported routine or exclusive use of RCP.31 In our study, neither longer
DHCA duration nor use of a predominant DHCA strategy during the Norwood procedure
emerged as an independent risk factor for any developmental outcome. No other perfusion
techniques used during cardiopulmonary bypass emerged as independent risk factors for
worse developmental outcomes despite a wide range of practices among participating
centers.
Most patient factors are not modifiable, but birth weight might be improved by postponing
the time of elective delivery to 39–40 weeks, as recommended by the American College of
Obstetricians and Gynecologists.32, 33 In a recent large series, 26% of neonates with critical
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congenital heart disease were delivered electively at 37–38 weeks gestation,34 a percentage
that is similar to national statistics.32
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The modest percentage of variance in outcomes explained by postnatal factors in our study
is consistent with growing evidence that risk for adverse neurodevelopmental outcomes
begins prenatally. Patients with HLHS have a high rate of cerebral dysgenesis and
microcephaly,35, 36 suggesting that genetic factors and epigenetic insults contribute to
abnormalities in brain development.12 Furthermore, abnormal fetal cerebral hemodynamics
could adversely affect brain development. Compared to normal third-trimester fetuses, those
with HLHS and other congenital heart lesions have progressively smaller gestational ageand weight-adjusted brain volume, as well as perturbed neuroaxonal development and
metabolism on fetal brain MRI.9 On histopathological examination, the HLHS fetus already
has chronic diffuse white matter injury.12 Preoperatively, abnormalities of brain metabolism
and microstructure, suggestive of brain immaturity, are present in a high percentage of
infants with single-ventricle lesions and D-transposition of the great arteries (D-TGA).37
Indeed, brain maturation in neonates with HLHS and D-TGA is delayed by approximately
one month compared to a normative sample.11 Moreover, Andropoulos et al.10 showed that
low brain maturity score by MRI is associated with greater brain injury in both the
preoperative and postoperative periods. Thus, preoperative condition could increase brain
vulnerability to perioperative hemodynamic instability and intraoperative hypoxia-ischemic
injury.
The results of this study must be viewed in light of its limitations. We are uncertain why the
clinical center at which the Norwood procedure was performed emerged as an independent
predictor of both PDI and MDI scores in final multivariable models. We prospectively
recorded data on many potential risk factors, including details of perfusion techniques.
Nonetheless, it is possible that differences in developmental scores according to site reflect
residual confounding from unmeasured variables in patient characteristics or perioperative
management. For example, neurotoxicity of anesthetic agents in the developing brain has
been an area of increasing concern,, but the types and quantities of anesthesia were not
recorded in the Single Ventricle Reconstruction trial.38–40 It is also possible that differences
in site scores were related to subjective differences in psychologist’s scoring at the centers.
However, the test administration technique of all psychologists was standardized centrally
prior to their testing of study subjects, and there was drift in scores over time at only one
site. Furthermore, study inferences were similar when centers were eliminated from the
multivariable models one at a time. Of note, the examiners were blinded to treatment group,
and shunt types were balanced within surgeon and thus, within clinical center, so that the
treatment group comparison should not be biased.
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We performed developmental testing at the oldest possible age within the design of the SVR
trial, for which 14-month development was a secondary outcome. It is difficult to assess
developmental skills such as visual perception, perceptual-motor integration, early number
concepts and or pre-writing skills before age two years. Bayley scores at 14 months are
poorly predictive of later neurodevelopment in normally-developing children, but their
predictive validity is better in samples of at-risk infants,41 including children with congenital
heart disease.42 The specificity and negative predictive value of low scores for later
cognitive function are relatively high;42, 43 children who score well in infancy tend to score
well later on. However, sensitivity and positive predictive value tend to be lower, indicating
that only a subset of children who score poorly in infancy will score poorly later on. This
may reflect many factors, including the benefits of early intervention and the influence of
intercurrent medical and psychosocial events. Poor PDI scores are, however, predictive of
later motor function, with strong tracking of motor proficiency from the 18-month PDI score
to the prepubertal period.44 Furthermore, the Bayley Scales at 14 months have good
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concurrent validity and reliability; because assessment of infants with congenital heart
disease has commonly been performed using the Bayley Scales at age one year, its use in the
current study allows comparison with previously published data.
We were unable to perform brain MRIs on study subjects because this would have required
general anesthesia in medically fragile children, posing a controversial risk-to-benefit ratio.
Neurologic examination also was not incorporated in the study protocol and would have
been challenging to standardize among 15 centers. Many variables were highly associated
with each other. We did not adjust for multiple comparisons in our analyses. However, the
P-values for the predictors in the final models were highly statistically significant. We used
bootstrapping to assess the reliability of variables that were selected in our multivariable
models, providing reassurance about their robustness. Intraoperative variables did not
emerge as independent predictors of neurodevelopmental outcomes, but adjustment for
postoperative events in the causal pathway may have diminished their statistical
significance. Finally, our study design allowed us to identify many of the variables
associated with adverse neurodevelopmental outcome, but not to determine causality.
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In summary, in the largest multi-center prospective study to date of children with HLHS and
other single right ventricle anomalies undergoing staged reconstruction, we found that
neurodevelopmental impairment was most highly associated with innate patient factors and
general medical morbidity in the first year of life. Substantial improvement in
neurodevelopmental outcome in this vulnerable population is likely to require interventions
that occur outside the operating room, such as discouraging elective deliveries before 39
weeks, protecting the brain during preoperative and postoperative hemodynamic instability,
and optimizing developmental support after Norwood discharge. While single ventricle
lesions and their management are unusually complex, they constitute an important model for
considering universal effects of critical congenital defects (both cardiac and non-cardiac)
requiring complex interventions in the newborn period.39
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Figure 1.

Flow chart of SVR trial subjects from randomization to neurodevelopmental follow-up.
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Figure 2.

Histogram depicting the number of subjects according to scores on the Psychomotor
Development Index (PDI, left panel) and Mental Development Index (MDI, right panel) of
the Bayley Scales of Infant Development®—Second Edition.
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